DISCLOSURE: The Policy on International Students has been ratified by IHL Fall 2016 to include additional requirements. The following is the amended policy:
IHL Policies & Bylaws §605.C- – TUBERCULOSIS:
Proof of test screening for tuberculosis by chest x-ray and interferon gamma release assays (IGRA) performed in the United States prior to the start of classes is required for all international students.
Logo image
Policy on International Students and TB Chest X-Ray
International Students (New, Transfer, and Continuing)
Office of Graduate Studies
Purpose:
The purpose is to comply with IHL Admission Policy for International students relative to communicable disease screening. IHL Policies & Bylaws § 605.C- – TUBERCULOSIS:
Proof of test screening for tuberculosis by chest x-ray and interferon gamma release assays (IGRA) performed in the United States prior to the start of classes are required for all international students.
Procedure for Compliance:
This policy and procedures establish the guidelines for Tuberculosis testing for all international students in compliance with IHL Policies and Bylaws. All first time international students must provide proof of TB screening and interferon gamma release assays (IGRA) performed in the United States that are no older than six-weeks prior to arrival to campus. Continuing international students must have evidence of their TB screening beginning spring 2016 and interferon gamma release assays as pre-condition to scheduling or enrolling in classes beginning spring 2017. In either case, under no circumstance shall any international student attend any class(es) or occupy any housing facilities without proof of test screening, in strict compliance with §605.C.
The only acceptable screenings for international students are the chest x-ray and the interferon gamma release assays (blood test). International students accepted for admission must have the appropriate documentation of tests performed in the United States prior to finalizing post-arrival procedures for reporting. Students must arrive in the United States in advance to allow time to conduct the tuberculosis screening and interferon gamma release assays. Verification of the screening results must be presented to the Office of Graduate Studies before reporting procedures and SEVIS registration will be completed by the Designated School Official (SSO). Students will receive notification of compliance once test results have been submitted.
A Disclosure notification will be sent to applicants as part of the admission process to apprise them of this requirement and the next steps if they are approved for admission. The chest x-ray and interferon gamma release assays must be done in the partnered facility. No x-rays from other facilities will be accepted.
Testing Process:
The chest x-ray and interferon gamma release arrays must be conducted by an authorized and licensed health care provider. The cost of the chest x-ray will be incurred by the student and must be in the form of cash, money order, or credit card.
Management of Test Results:
An acceptable test result is “negative”. Laboratory reports must state the findings. Individuals who screen positive will not be admitted.Test results must be submitted in a sealed envelope from the medical provider.